Clinical Trials Directory

Trials / Completed

CompletedNCT03319264

Sarcopenia in Axial and Peripheral Spondyloarthropathies

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
106 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Spondylarthropathies (SpA) are among the most common chronic inflammatory rheumatisms in adults, responsible for a muscular loss or sarcopenia which can be very disabling, not much documented in the literature, and not yet studied in France. In addition, sarcopenia is associated with decreased physical activity and increased risk of falls and fractures. A better characterization of the determinants of this muscular loss will allow to better detect and take care of it. The aim is to conduct the first French study on the prevalence and severity of sarcopenia in patients with spondyloarthropathies and to study the variables that may be associated with it. Finally, we propose to evaluate obesity related to sarcopenia in these patients and compare them to cases matched for age and sex (from OFELY / STRAMBO cohorts, Lyon, FRANCE). This is a prospective interventional and monocentric study with minimal risks and constraints: patients will be included for one day for an evaluation of their sarcopenia by measuring their muscle strength, physical performance and body composition and recording of their socio-demographic and disease characteristics.

Conditions

Interventions

TypeNameDescription
OTHERDynamometry examPrehension strength of the main hand will be assessed thanks to dynamometry, in order to evaluate patient's muscular strength
OTHERWalking testA 4 metres walking test will be performed to assess patient's walking speed
RADIATIONDXA measurementDXA measurement will be performed to assess patient's body composition
OTHERSARQOL questionnairePatient's quality of life will be assessed thanks to the SARQOL questionnaire
BEHAVIORALLife habits QuestionnaireLife habits Questionnaire

Timeline

Start date
2017-11-02
Primary completion
2018-07-04
Completion
2018-07-04
First posted
2017-10-24
Last updated
2025-12-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03319264. Inclusion in this directory is not an endorsement.